Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of The Topical Combined Application of Dexamethasone, Ascorbic Acid, and β-Sodium Glycerophosphate on Implant Osseointegration: A Randomized Clinical Trial

NCT07060859 is registered in ClinicalTrials.gov with Manar Ziad Foura-Matar as lead sponsor.

NCT NCT07060859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07060859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of The Topical Combined Application of Dexamethasone, Ascorbic Acid, and β-Sodium Glycerophosphate on Implant Osseointegration: A Randomized Clinical Trial
Lead sponsor
Manar Ziad Foura-Matar
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2023
Completion date
September 30, 2023
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

implant stability and osseointegration